Medical Care of Cancer Patients During the COVID-19 Pandemic - an Analysis of Health Insurance Claims Data

Status: Completed
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The focus on treatment of COVID19 patients during the Sars-CoV-2 outbreak has most likely implications for the extent and quality of diagnosis and treatment of non-COVID19 patients. Medical care of cancer patients is a particularly sensitive area. To draw holistic conclusions, it is necessary to analyze the provision of healthcare as broadly as possible with regard to the dimensions of access, processes and outcome during the Sars-CoV-2 pandemic. This will be implemented exemplarily for the early detection, diagnosis and treatment of colorectal cancer (CRC) and pancreatic cancer (PaCa) in Saxony. Patients with diagnosis, treatment or early detection measures for type 2 diabetes (T2D), coronary heart disease (CHD) and multiple sclerosis (MS) serve as comparison groups.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Healthy Volunteers: No
View:

• Resident of Saxony, Germany with health insurance coverage provided by AOK PLUS

• Diagnosis of colorectal cancer, pancreatic cancer, type 2 diabetes, coronary heart disease or multiple sclerosis between in 2019 or 2020 according to ICD-10

Locations
Other Locations
Germany
ZEGV
Dresden
Time Frame
Start Date: January 1, 2019
Completion Date: December 31, 2020
Participants
Target number of participants: 6500
Sponsors
Leads: Technische Universität Dresden
Collaborators: Medizinische Fakultät der Martin-Luther-Universität Halle-Wittenberg, German Federal Ministry of Education and Research, AOK PLUS, Ruhr-Universität Bochum

This content was sourced from clinicaltrials.gov

Similar Clinical Trials